A new chapter in the 340B Drug Pricing Program is unfolding as the Health Resources & Services Administration (“HRSA”) pursues its 340B Rebate Model Pilot Program (the “Pilot Program”)—a move ...

One of the world’s biggest drug makers is suing the country’s smallest state. The argument is over a federal drug discount ...

As a Crohn’s and colitis and Hidradenitis Suppurativa patient in Greensboro, I’ve experienced many sides of our health care ...

CMS proposed in July to expedite its payment reduction for some 340B items and services until it recoups $7.8 billion. Hospital systems are pushing back. To compensate for underpayments in the 340B ...

Hospitals and major drugmakers are battling over the financial impact of a government pilot program that could shake up how medicines are steeply discounted for low-income and uninsured patients.

The U.S. Court of Appeals for the 5th Circuit upheld a Mississippi court decision to deny drugmaker AbbVie’s request for a preliminary injunction against a state law protecting access to 340B drug ...

On September 12, 2025, the United States Court of Appeals for the Fifth Circuit, in AbbVie v. Fitch, Case No. 24-60375, (5th Cir. 2025), affirmed a federal District Court’s denial of a preliminary ...

The United States Court of Appeals for the Fifth Circuit Sept. 12 affirmed a Mississippi Court’s decision to deny AbbVie’s ...

Pennsylvania’s state-administered AIDS Drug Assistance Program (ADAP), will implement new income eligibility limits on ...